Search Results - "Zahm, F E"

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B by Cooksley, W G E, Piratvisuth, T, Lee, S-D, Mahachai, V, Chao, Y-C, Tanwandee, T, Chutaputti, A, Chang, W Yu, Zahm, F E, Pluck, N

“…Current therapies for chronic hepatitis B (CHB) have a number of limitations, and better treatment options are needed. Peginterferon alpha-2a (40 kDa) is…”
Get full text

Peginterferon α-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B by Cooksley, W. G. E., Piratvisuth, T., Lee, S.-D., Mahachai, V., Chao, Y.-C., Tanwandee, T., Chutaputti, A., Chang, W. Yu, Zahm, F. E., Pluck, N.

“…Current therapies for chronic hepatitis B (CHB) have a number of limitations, and better treatment options are needed. Peginterferon α‐2a (40 kDa) is superior…”
Get full text

Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology by Zahm, F E, Bonino, F, Giuseppetti, R, Rapicetta, M

“…Ganciclovir is a nucleoside analogue active against cytomegalovirus. The compound has also shown in vitro and in vivo activity against duck hepatitis B virus…”
Get more information

Treatment of woodchuck hepatitis virus infection in vivo with 2', -3'-dideoxycytidine (ddC) and 2',-3'-dideoxycytidine monophosphate coupled to lactosaminated human serum albumin (L-HSA ddCMP) by Zahm, F E, d'Urso, N, Bonino, F, Ponzetto, A

“…Dideoxycytidine (ddC) is a nucleoside analogue active against human immunodeficiency virus and with in vitro activity against human hepatitis B virus. We…”
Get more information

Viral hepatitis and its treatment. Present and future by Zahm, F E

Get more information